Insider Transactions in Q1 2025 at Aadi Bioscience, Inc. (AADI)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 04
2025
|
Anupam Dalal |
BUY
Grant, award, or other acquisition
|
Indirect |
1,561,000
+31.4%
|
$3,122,000
$2.4 P/Share
|
Mar 04
2025
|
Caley Castelein |
BUY
Grant, award, or other acquisition
|
Indirect |
1,666,000
+43.48%
|
$3,332,000
$2.4 P/Share
|
Mar 04
2025
|
Bryan Ball |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+33.02%
|
$200,000
$2.4 P/Share
|
Mar 04
2025
|
Baiteng Zhao |
BUY
Grant, award, or other acquisition
|
Indirect |
1,250,000
+50.0%
|
$2,500,000
$2.4 P/Share
|
Mar 03
2025
|
Bryan Ball |
SELL
Open market or private sale
|
Direct |
2,147
-2.04%
|
$4,294
$2.35 P/Share
|
Mar 03
2025
|
David James Lennon CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,690
-14.55%
|
$11,380
$2.35 P/Share
|
Mar 03
2025
|
Scott M. Giacobello CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,806
-10.49%
|
$5,612
$2.35 P/Share
|
Mar 01
2025
|
Bryan Ball |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.55%
|
-
|
Mar 01
2025
|
David James Lennon CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,250
+29.35%
|
-
|
Mar 01
2025
|
Scott M. Giacobello CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,750
+20.15%
|
-
|